• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Valeant Pharmaceuticals International Inc

+ Add to Watchlist

BVF:GR

92.224 EUR 0.564 0.62%

As of 09:37:39 ET on 07/25/2014.

Snapshot for Valeant Pharmaceuticals International Inc (BVF)

Open: 91.970 Day's Range: 91.968 - 92.224 Volume: 0
Previous Close: 91.660 52wk Range: 68.378 - 112.510 1-Yr Rtn: +33.21%

Stock Chart for BVF

No chart data available.
  • BVF:GR 92.224
  • 1D
  • 1M
  • 1Y
91.660
Interactive BVF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BVF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 14.2550
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.6880
Est. PEG Ratio 0.8778
Market Cap (M EUR) 30,763.36
Shares Outstanding (M) 333.57
30 Day Average Volume 219
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.0000
Dividend Ex-Date 11/10/2010
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BVF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BVF

Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.

J Michael Pearson "Mike"Chairman/CEOPavel MirovskyPresident/Gen Mgr:Europe
Laizer D KornwasserGroup Chairman/Exec VPHoward B SchillerExec VP/CFO
More Company Profile & Key Executives for BVF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil